An unsupervised clustering of the cell lines by their DSS profiles showed that MM cell lines with PI3K and NRAS/KRAS mutations displayed high sensitivity to MEK and PI3K inhibitors, respectively (Figure 1A). Here, MAP2K7 is linked to Miyoshi myopathy.